-
Health Commission: The 19 newly diagnosed cases on the 31st were all imported from abroad
Time of Update: 2021-09-10
As of 24:00 on August 31, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 1,022 confirmed cases (including 3 severe cases), a total of 89,240 cured and discharged cases, and a total of 4,636 deaths.
-
Who is given the booster shot and how?
Time of Update: 2021-09-10
" Zheng Zhongwei, the leader of the vaccine research and development team of the State Council's Joint Prevention and Control Mechanism Scientific Research Group, gave a set of data: in severe cases People who have completed the immunization program for more than 14 days account for less than 5% of severe cases.
-
Chen Wei and other experts: Adenovirus vector vaccine is strengthened better
Time of Update: 2021-09-10
However, this study is the first to report the sequential primary immunization of SARS-CoV-2 inactivated vaccine (CoronaVac) and recombinant adenovirus type 5 vector vaccine (Convidecia)-booster immunization in China 18-59 years old Safety and immunogenicity in adults .
-
People who have experienced the traceability of the new crown virus: How and where is the global traceability?
Time of Update: 2021-09-10
Zhou Lei: Your question brings my whole thoughts back to the unforgettable period in which we were in Wuhan at the beginning of this year, and for a longer period of time before that, when we and the World Health Organization’s international expert team jointly carried out the first phase of the global traceability study in China.
-
Infectious disease expert: anthrax is rarely transmitted from person to person, scientific prevention is the key
Time of Update: 2021-09-10
Mao Xiaorong believes that irregular livestock vaccination, non-strict quarantine and unscientific slaughter methods may be the main causes of anthrax infection .
"Of the cases discovered so far, most of the people infected with anthrax are herders or people who are engaged in breeding and slaughtering cattle, sheep and livestock and selling related products.
-
28 new cases were confirmed on September 1, including 1 local case
Time of Update: 2021-09-10
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on September 1 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on September
-
With nearly $5 billion smashed in two months, can Pfizer's oncology business break through?
Time of Update: 2021-09-10
Accumulated investment of more than 10 billion US dollars betting on oncology business It is understood that Trillium’s main products are two SIRPα-Fc fusion proteins TTI-622 and TTI-621, currently in clinical phase 1b/2, targeting the CD-47-SIRPα pathway, mainly suitable for hematological malignancies .
-
Health Commission: 23 newly confirmed cases are all imported cases
Time of Update: 2021-09-10
As of 24:00 on August 29, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1175 confirmed cases (including 7 severe cases), a total of 89,031 cured and discharged cases, and a total of 4,636 deaths.
-
Is there a second generation of the new crown vaccine?
Time of Update: 2021-09-10
Authoritative response from the vaccine research and development class Is there a second generation of the new crown vaccine?
Authoritative response from the vaccine research and development class Science and Technology Daily reporter Zhang Jiaxing At the just-concluded service trade fair, the second-generation new crown vaccine was unveiled .
-
Notice on launching outstanding clinical case results solicitation and selection activities
Time of Update: 2021-09-10
Notice on launching outstanding clinical case results solicitation and selection activities Notice on Carrying out Outstanding Clinical Case Achievement Collection and Selection Act
-
my country has achieved full coverage of clinical trials on 5 technical routes for vaccine research and development
Time of Update: 2021-09-10
What new progress is there now?State Council In this regard, Zheng Zhongwei pointed out that China has laid out 5 technical routes from the beginning of the outbreak to promote the research and development of new coronavirus vaccines, including inactivated vaccines, adenovirus vector vaccines, recombinant protein vaccines, attenuated influenza virus vector vaccines and nucleic acid vaccines.
-
Health Commission: Newly confirmed 32 new cases of new crown on the 26th, 2 local cases
Time of Update: 2021-09-10
As of 24:00 on August 26, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1431 confirmed cases (including 12 severe cases), a total of 88,698 cured and discharged cases, and a total of 4,636 deaths.
-
Health Commission: 36 newly diagnosed cases on the 6th, all imported cases
Time of Update: 2021-09-10
As of 24:00 on September 6, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 826 confirmed cases (including 7 severe cases), 89,602 cured and discharged cases, and 4,636 deaths.
-
Separating the pharmaceutical sector, Dongyang Sunshine will no longer engage in the production and sales of pharmaceutical products!
Time of Update: 2021-09-10
Through this transaction, Dongyang Sunshine stated that since the company's resource advantages such as talents, technology and channels are mainly concentrated in related fields such as new electronic materials, the future investment of a large amount of resources into Dongyang Sun Pharmaceutical’s transformation and transformation is not conducive to giving full play to its comparative advantages.
-
Two-pronged approach to combat resistance to breast cancer treatment
Time of Update: 2021-09-10
They designed and synthesized a class of dual-mechanism estrogen receptor inhibitors (DMERIs) and revealed a new conformational model that effectively inhibits the activity of estrogen receptors, providing a new strategy for the development of endocrine-resistant breast cancer drugs .
-
Liu Hong: Be a medicine man with one heart and one mind
Time of Update: 2021-09-10
After working hard day and night for several months, the research team made important progress and discovered a new type of novel coronavirus pneumonia virus candidate drug with novel structure, high efficiency and safety .
-
AIDS vaccine trial meets another setback
Time of Update: 2021-09-10
In a trial called Imbokodo that began in 2017, a vaccine produced by Johnson & Johnson failed to provide convincing protection against HIV infection .
Johnson & Johnson Chief Scientific Officer Paul Stoffels said that despite the failure, a second trial of similar vaccines in different study populations will continue .
-
The Ministry of Medical Science issued a guide to guide the original exploration plan project guide
Time of Update: 2021-09-10
Scientific Goal 2.
Core Scientific Issue 3.
Main Funding Direction 4.
Funding Plan 5.
Application requirements 6.
Application procedures for projects with inaccurate or unselected selections above will not be funded .
-
The first!
Time of Update: 2021-09-10
This year, Baekje will continue to participate in medical insurance negotiations for the indication of bone metastasis of solid tumors and the prevention of bone-related events in patients with multiple myeloma, with a view to including this indication in medical insurance .
-
New nanomaterials can enhance the anti-coronavirus effect of dendritic cell vaccines
Time of Update: 2021-09-10
In this research, the team innovatively used large-scale (sheet diameter greater than 1 micron) graphene oxide nanosheet materials to engineer dendritic cell vaccines, thereby promoting the "immunity between dendritic cells and T cells" The formation of "synapses" and the aggregation of cell clusters reveal for the first time that two-dimensional nanosheet materials have potential applications as adjuvants for broad-spectrum dendritic cell vaccines .
